These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 1681364)

  • 1. Overview of azathioprine treatment in multiple sclerosis.
    Yudkin PL; Ellison GW; Ghezzi A; Goodkin DE; Hughes RA; McPherson K; Mertin J; Milanese C
    Lancet; 1991 Oct; 338(8774):1051-5. PubMed ID: 1681364
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Double-masked trial of azathioprine in multiple sclerosis. British and Dutch Multiple Sclerosis Azathioprine Trial Group.
    Lancet; 1988 Jul; 2(8604):179-83. PubMed ID: 2899660
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The efficacy of azathioprine in relapsing-remitting multiple sclerosis.
    Goodkin DE; Bailly RC; Teetzen ML; Hertsgaard D; Beatty WW
    Neurology; 1991 Jan; 41(1):20-5. PubMed ID: 1985289
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A long-term double-blind controlled study on the effect of azathioprine in the treatment of multiple sclerosis.
    Minderhoud JM; Prange AJ; Luyckx GJ
    Clin Neurol Neurosurg; 1988; 90(1):25-8. PubMed ID: 3359729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A double blind study on azathioprine efficacy in multiple sclerosis: final report.
    Milanese C; La Mantia L; Salmaggi A; Eoli M
    J Neurol; 1993 May; 240(5):295-8. PubMed ID: 8326334
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Double blind controlled randomized study on azathioprine efficacy in multiple sclerosis. Preliminary results.
    Milanese C; La Mantia L; Salmaggi A; Campi A; Bortolami C; Tajoli L; Nespolo A; Corridori F
    Ital J Neurol Sci; 1988 Feb; 9(1):53-7. PubMed ID: 3281916
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interferon, azathioprine and corticosteroids in multiple sclerosis: 6-year follow-up of the ASA cohort.
    Kalincik T; Horakova D; Dolezal O; Krasensky J; Vaneckova M; Seidl Z; Havrdova E
    Clin Neurol Neurosurg; 2012 Sep; 114(7):940-6. PubMed ID: 22402204
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mitoxantrone: a review of its use in multiple sclerosis.
    Scott LJ; Figgitt DP
    CNS Drugs; 2004; 18(6):379-96. PubMed ID: 15089110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Azathioprine for multiple sclerosis.
    Casetta I; Iuliano G; Filippini G
    J Neurol Neurosurg Psychiatry; 2009 Feb; 80(2):131-2; discussion 132. PubMed ID: 19151017
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclosporine versus azathioprine in the long-term treatment of multiple sclerosis--results of the German multicenter study.
    Kappos L; Patzold U; Dommasch D; Poser S; Haas J; Krauseneck P; Malin JP; Fierz W; Graffenried BU; Gugerli US
    Ann Neurol; 1988 Jan; 23(1):56-63. PubMed ID: 3278672
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A placebo-controlled, randomized, double-masked, variable dosage, clinical trial of azathioprine with and without methylprednisolone in multiple sclerosis.
    Ellison GW; Myers LW; Mickey MR; Graves MC; Tourtellotte WW; Syndulko K; Holevoet-Howson MI; Lerner CD; Frane MV; Pettler-Jennings P
    Neurology; 1989 Aug; 39(8):1018-26. PubMed ID: 2668784
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Azathioprine in multiple sclerosis--a 3 year controlled study of its effectiveness.
    Patzold U; Pocklington P
    J Neurol; 1980; 223(2):97-117. PubMed ID: 6157007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prolonged treatment of multiple sclerosis with average doses of azathioprine. An evaluation of 15 years' experience].
    Lhermitte F; Marteau R; Roullet E; de Saxcé H; Loridan M
    Rev Neurol (Paris); 1984; 140(10):553-8. PubMed ID: 6438761
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Azathioprine in treatment of multiple sclerosis. Final results of a 41/2-year controlled study of its effectiveness covering 115 patients.
    Patzold U; Hecker H; Pocklington P
    J Neurol Sci; 1982 Jun; 54(3):377-94. PubMed ID: 7047686
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk of cancer from azathioprine therapy in multiple sclerosis: a case-control study.
    Confavreux C; Saddier P; Grimaud J; Moreau T; Adeleine P; Aimard G
    Neurology; 1996 Jun; 46(6):1607-12. PubMed ID: 8649558
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Immunosuppressive therapy of multiple sclerosis using cyclosporin A and azathioprine. Long-term effects, risks, proton spin tomography and immunological findings].
    Kappos L
    Schriftenr Neurol; 1990; 32():1-200. PubMed ID: 2200108
    [No Abstract]   [Full Text] [Related]  

  • 17. Azathioprine versus beta interferons for relapsing-remitting multiple sclerosis: a multicentre randomized non-inferiority trial.
    Massacesi L; Tramacere I; Amoroso S; Battaglia MA; Benedetti MD; Filippini G; La Mantia L; Repice A; Solari A; Tedeschi G; Milanese C
    PLoS One; 2014; 9(11):e113371. PubMed ID: 25402490
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness of azathioprine treatment in multiple sclerosis.
    Fratiglioni L; Siracusa GF; Amato MP; Sità D; Amaducci L
    Ital J Neurol Sci; 1988 Jun; 9(3):261-4. PubMed ID: 3403219
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histocompatibility antigens in multiple sclerosis patients participating in a multicentre trial of azathioprine. British & Dutch Multiple Sclerosis Azathioprine Trial Group.
    J Neurol Neurosurg Psychiatry; 1988 Mar; 51(3):412-5. PubMed ID: 3283297
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term treatment of multiple sclerosis with azathioprine.
    Swinburn WR; Liversedge LA
    J Neurol Neurosurg Psychiatry; 1973 Feb; 36(1):124-6. PubMed ID: 4632435
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.